4//SEC Filing
Weisblum Eric 4
Accession 0001213900-23-097689
CIK 0001514183other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:13 PM ET
Size
7.3 KB
Accession
0001213900-23-097689
Insider Transaction Report
Form 4
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
- Purchase
Common Stock
2023-12-19$1.63/sh+500$815→ 169,724 total - Purchase
Common Stock
2023-12-20$1.61/sh+200$322→ 169,924 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.65. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.63. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Silo Pharma, Inc.
CIK 0001514183
Entity typeother
Related Parties
1- filerCIK 0001569077
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:13 PM ET
- Size
- 7.3 KB